Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 17, 2021

SELL
$3.01 - $3.78 $62,168 - $78,072
-20,654 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.33 - $6.5 $3,043 - $5,941
914 Added 4.63%
20,654 $78,000
Q4 2020

Feb 16, 2021

BUY
$2.88 - $4.33 $56,851 - $85,474
19,740 New
19,740 $77,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.